Activity
-
We are actively recruiting for a Program Manager Specialist in the Children’s Hospital of Philadelphia Mitochondrial Medicine Frontier Program!…
We are actively recruiting for a Program Manager Specialist in the Children’s Hospital of Philadelphia Mitochondrial Medicine Frontier Program!…
Liked by Josh Barer
-
Congrats to the BioStar Capital team! Only 3 investment firms mentioned globally across industries (per Pitchbook email blast). Seemingly the #1 best…
Congrats to the BioStar Capital team! Only 3 investment firms mentioned globally across industries (per Pitchbook email blast). Seemingly the #1 best…
Liked by Josh Barer
-
It's officially been one year since APGE became a publicly traded company! Thank you to our friends at Nasdaq for celebrating this milestone with us.…
It's officially been one year since APGE became a publicly traded company! Thank you to our friends at Nasdaq for celebrating this milestone with us.…
Liked by Josh Barer
Experience & Education
Languages
-
English
Native or bilingual proficiency
-
Hebrew
Limited working proficiency
-
Arabic
Elementary proficiency
-
German
Elementary proficiency
More activity by Josh
-
Celebrated my 12 year work anniversary yesterday - time flies when you’re having fun! Check out the vintage logo ✔️
Celebrated my 12 year work anniversary yesterday - time flies when you’re having fun! Check out the vintage logo ✔️
Liked by Josh Barer
-
We are hiring! Loooking for a new associate to join our team. The candidate must have a science background. Position is based in…
We are hiring! Loooking for a new associate to join our team. The candidate must have a science background. Position is based in…
Liked by Josh Barer
-
We are excited to announce the latest Innovation Evergreen Fund Investment!
We are excited to announce the latest Innovation Evergreen Fund Investment!
Liked by Josh Barer
-
While we are disappointed with the topline results of the Phase 3 soticlestat trials announced by Takeda, medical research is not without risk. It is…
While we are disappointed with the topline results of the Phase 3 soticlestat trials announced by Takeda, medical research is not without risk. It is…
Liked by Josh Barer
-
Very exciting day for Matthew Pauls & the amazing team at Savara Inc. - IMPALA-2, the company's pivotal, Phase 3 clinical trial of molgramostim for…
Very exciting day for Matthew Pauls & the amazing team at Savara Inc. - IMPALA-2, the company's pivotal, Phase 3 clinical trial of molgramostim for…
Liked by Josh Barer
Other similar profiles
-
Skylar Bennethum
Bluprint Ventures
Connect -
Jim Bennethum
Connect -
Christopher ("Chris") Jeffers
Connect -
Ido Zairi
Managing Partner at Israel Biotech Fund
Connect -
Moniza Khokhar
Serial Entrepreneur
Connect -
Steven Nichtberger, MD
Connect -
Anthony Schwartz
Connect -
Brian M Strem
Connect -
Kevin Slawin MD
Connect -
Ginger Johnson
Connect
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore More